A R Yallowitz
Overview
Explore the profile of A R Yallowitz including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
5
Citations
276
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Alexandrova E, Yallowitz A, Li D, Xu S, Schulz R, Proia D, et al.
Nature
. 2015 Sep;
527(7578):398.
PMID: 26416737
No abstract available.
2.
Yallowitz A, Hanel W, Moll U
Cell Death Differ
. 2015 Jun;
22(8):1397.
PMID: 26045050
No abstract available.
3.
Alexandrova E, Yallowitz A, Li D, Xu S, Schulz R, Proia D, et al.
Nature
. 2015 May;
523(7560):352-6.
PMID: 26009011
Missense mutations in p53 generate aberrant proteins with abrogated tumour suppressor functions that can also acquire oncogenic gain-of-function activities that promote malignant progression, invasion, metastasis and chemoresistance. Mutant p53 (mutp53)...
4.
Yallowitz A, Alexandrova E, Talos F, Xu S, Marchenko N, Moll U
Cell Death Differ
. 2014 Jan;
21(4):645-54.
PMID: 24440910
In embryogenesis, p63 is essential to develop mammary glands. In the adult mammary gland, p63 is highly expressed in the basal cell layer that comprises myoepithelial and interspersed stem/progenitor cells,...
5.
Vaseva A, Yallowitz A, Marchenko N, Xu S, Moll U
Cell Death Dis
. 2011 May;
2:e156.
PMID: 21562588
Strategies to induce p53 activation in wtp53-retaining tumors carry high potential in cancer therapy. Nutlin, a potent highly selective MDM2 inhibitor, induces non-genotoxic p53 activation. Although Nutlin shows promise in...